agilon health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-354.54	-391.35	-260.1	-262.8	-106.86	-406.79
Depreciation & Amortization	28.51	28.59	24.46	20.16	13.77	14.67
Stock-Based Compensation	38.65	49.12	50.66	69.5	28.38	292.39
Other Adjustments	-18.64	18.4	-6.98	27.02	-6.66	6.59
Change in Receivables	-	344.59	-74.58	-460.37	-204.17	-149.04
Changes in Accounts Payable	-	-85.59	4.64	32.11	65.74	19.36
Changes in Other Operating Activities	137.17	-69.53	200.53	418.19	79	74.66
Operating Cash Flow	-50.05	-105.76	-57.78	-156.2	-130.81	-148.16
Capital Expenditures	-12.49	-13.24	-13.25	-15.83	-15.43	-6.56
Purchases of Intangible Assets	-22.86	-29.87	-28.03	-14.99	-17.24	-6.86
Purchases of Investments	-12.64	-60.15	-12.01	-114.66	-458.27	-
Proceeds from Sale of Investments	180.96	193.87	206.92	164.04	52.55	7.1
Payments for Business Acquisitions	-	-	-	-45.25	-	-
Proceeds from Business Divestments	-	-	-	2.19	0.5	-1.34
Other Investing Activities	-1.5	-2	-13.73	-19.53	-6.51	-82.83
Investing Cash Flow	130.97	88.61	139.89	-44.02	-444.39	-90.51
Long-Term Debt Issued	-	-	-	-	-	100
Long-Term Debt Repaid	-3.5	-	-3.75	-5	-5	-119.9
Net Long-Term Debt Issued (Repaid)	-3.5	-	-3.75	-5	-5	-19.9
Issuance of Common Stock	-2.87	-2.99	1.17	11.87	33.06	1,189
Repurchase of Common Stock	-	-	-	-200	-	-
Net Common Stock Issued (Repurchased)	-2.87	-2.99	1.17	-188.13	33.06	1,189
Other Financing Activities	-1.61	-	-	-	-	-14.74
Financing Cash Flow	-7.98	-2.99	-2.58	-193.13	28.06	1,154
Net Cash Flow	72.94	-20.15	79.53	-393.35	-547.14	915.73
Free Cash Flow	-62.54	-119.01	-71.03	-172.03	-146.23	-154.72
FCF Margin	-1.07%	-2.01%	-1.17%	-3.99%	-6.12%	-10.17%
Free Cash Flow Per Share	-3.77	-7.19	-4.32	-10.52	-8.96	-10.37
Levered Free Cash Flow	-204.86	-531.11	-47.52	187.03	31.53	-324.26
Unlevered Free Cash Flow	-285.22	-604.43	-77.45	221.55	35.79	-270.98

SEC Filings: 10-K · 10-Q